BULLFROG AI HOLDINGS, INC. Accounts Payable
BULLFROG AI HOLDINGS, INC. (BFRG) had Accounts Payable of $169.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $169.94K.
- 2026-03-31: Accounts Payable, Current $216.99K.
- 2025-12-31: Accounts Payable, Current $168.15K.
- 2025-09-30: Accounts Payable, Current $168.21K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $169.94K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $216.99K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $168.15K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $168.21K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $181.79K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $210.53K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $435.93K 10-K · filed 2026-03-19 |
| 2024-09-30 | $91.37K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $82.02K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $154.54K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $103.66K 10-K · filed 2025-03-14 |
| 2023-09-30 | $110.50K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $490.71K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $636.89K 10-Q · filed 2023-05-24 |
| 2022-12-31 | $543.99K 10-K · filed 2024-03-29 |
| 2021-12-31 | $68.59K 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |